DJ Eli Lilly & Co. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. $(LLY)$ slid 1.07% to $868.88 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.67% to 6,066.44 and the Dow Jones Industrial Average rising 0.38% to 44,470.41.
The stock's fall snapped a four-day winning streak.
Eli Lilly & Co. closed 10.66% below its 52-week high of $972.53, which the company reached on August 22nd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.73% to $154.24, Pfizer Inc. $(PFE)$ rose 0.51% to $25.87, and AbbVie Inc. $(ABBV)$ fell 0.14% to $190.34.
Trading volume (3.1 M) remained 640,418 below its 50-day average volume of 3.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 10, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 10, 2025 16:31 ET (21:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。